Replies to post #337673 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Catalysts to Drive Value in 2021
The company has multiple clinical milestones

> Top-line data AVATAR: Potentially pivotal Phase 2/3 adult RTT clinical trial – expected 2H 2021

>. Top-line data Phase 1 ANAVEX®3-71 clinical trial – expected 2H 2021

>. Initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical trial – expected 2021


Pipeline expansion opportunities for ANAVEX®2-73

> Initiation of potentially pivotal Phase 2/3 Fragile X clinical trial – expected 2021

> Initiation of potentially pivotal Phase 2/3 clinical trial for the treatment of a new, rare disease
indication – expected 2021

https://e1cd7807-443e-425e-9433-41548681800c.filesusr.com/ugd/73f698_021c7a1cb7a24d78b02dac05e7262ef7.pdf

Good luck and GOD bless,

[XenaLives]

5% up on a generally difficult market day is FANTASTIC!!!!